1.87 USD
↗ 0.02 (1.29%)PRE MARKET (AS OF 04:06 AM EDT)
Milestone Pharmaceuticals Inc. Common Shares
MISTNASDAQ • USD
Market: OPEN
Open?$1.88
High?$1.88
Low?$1.88
Prev. Close?$1.86
Volume?N/A
Avg. Volume?2.7M
Bid / Ask
Bid?$1.87 × 300
Ask?$1.92 × 300
Spread?$0.05
Midpoint?$1.90
Valuation & Ratios
Market Cap?218.9M
Shares Out?117.7M
Float?74.8M
Float %?87.8%
P/E Ratio?N/A
P/B Ratio?-15.77
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.01Strong
Quick Ratio?7.96Strong
Cash Ratio?5.23Strong
Debt/Equity?-4.12Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-15.77CHEAP▾
P/S?141.57HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
EV/Sales?131.31HIGH▾
Returns & Efficiency
ROE?454.3%STRONG▾
ROA?-55.5%WEAK▾
Cash Flow & Enterprise
FCF?$-49343000
Enterprise Value?$203.0M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
222.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444